Serum Amylase 1

• A decline in serum levels in patients treated with icodextrin is observed

• Return to baseline after cessation of treatment

• Not associated with any clinical adverse event

Diapositiva anterior

Diapositiva siguiente

Ir a la primera diapositiva

Ver versión gráfica